X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/16/2863683/0/en/Nacuity-Pharmaceuticals-Expands-Board-of-Directors-with-Appointment-of-Dr-Emmett-Cunningham-Jr.html
https://www.globenewswire.com//news-release/2024/03/12/2844590/0/en/Arctic-Therapeutics-and-Nacuity-Pharmaceuticals-Announce-European-Medicines-Agency-Approval-to-Initiate-First-Clinical-Trial-of-AT-001-NPI-001-for-the-Treatment-of-HCCAA.html
https://www.globenewswire.com//news-release/2024/02/14/2829109/0/en/Nacuity-Pharmaceuticals-Announces-Expansion-of-its-Business-Advisory-Board-with-Appointment-of-Rare-Disease-Advocate-Daniel-Feller.html
https://www.globenewswire.com/news-release/2023/07/11/2702711/0/en/Nacuity-Pharmaceuticals-Advances-Phase-1-2-Clinical-Trial-Evaluating-NPI-002-Intravitreal-Implant-for-the-Delay-of-Cataract-Progression.html
https://www.clinicaltrialsarena.com/news/nacuity-target-enrolment-rp-trial/
https://www.globenewswire.com/news-release/2023/05/31/2679465/0/en/Nacuity-Pharmaceuticals-Achieves-Target-Enrollment-for-Phase-1-2-Clinical-Trial-of-NPI-001-for-the-Treatment-of-Retinitis-Pigmentosa-Associated-with-Usher-Syndrome.html
https://www.globenewswire.com/news-release/2022/11/08/2551015/0/en/Nacuity-Pharmaceuticals-Expands-Board-of-Directors-with-Appointment-of-Dr-Russell-Kelley.html
https://www.biospace.com/article/releases/nacuity-pharmaceuticals-expands-board-of-directors-with-appointment-of-dr-russell-kelley/#:~:text=FORT%20WORTH%2C%20Texas%2C%20Nov.,MBA%2C%20to%20its%20board%20of
https://www.globenewswire.com/news-release/2022/09/13/2515088/0/en/Nacuity-Pharmaceuticals-and-Arctic-Therapeutics-Enter-Licensing-Agreement-and-Strategic-Partnership-to-Develop-NPI-001.html
https://www.globenewswire.com/news-release/2022/06/15/2462987/0/en/Nacuity-Pharmaceuticals-Announces-16-5-Million-Series-B-Financing-Led-by-Foundation-Fighting-Blindness-RD-Fund.html
Market Place
Share 
